Comparing biologic drugs for rheumatoid arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study compares two types of medication for rheumatoid arthritis to see which one might be better. It looks at how these drugs affect your daily life and physical abilities. If you have RA and are on one of these drugs, this study could help you understand your treatment better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with rheumatoid arthritis.
- You are between 18 and 65 years old.
- You have been taking an anti-TNF or non-TNF biologic drug for 1 to 3 years.
- You do not exercise regularly (3 or more days per week).
- You do not have a serious health condition (like cancer, heart disease, or a physical disability that prevents cycling).
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medical device to help people with rheumatoid arthritis stay in remission while on biologic therapy. The goal is to see if the device can prevent flares and maintain disease control.
This trial tests a new drug called telitacicept for people with rheumatoid arthritis (RA) that hasn't improved after trying multiple treatments. It aims to see if the drug can reduce joint pain and swelling when other medications have failed.
This study looks at how rheumatoid arthritis affects daily activities and quality of life. By understanding disability levels, researchers hope to improve care and support for patients.
This trial compares two additional medicines (diosmin or rebamipide) taken with standard arthritis treatment to see if they help reduce joint pain and swelling better than standard treatment alone.
This study compares two different ways of slowly lowering the dose of steroids (like prednisolone) in people with stable rheumatoid arthritis. The goal is to see which tapering schedule is safer and more effective, possibly reducing side effects while keeping the disease under control.
This Phase 3 study compares two ways to treat active rheumatoid arthritis: a TNF-blocking biologic versus a targeted pill treatment. It may help people who are not doing well on (or cannot tolerate) certain biologic therapies to find a better, more practical option.
Hear when a new Rheumatoid Arthritis (RA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.